Why Embla Medical stock moves
Embla Medical fell, moving in line with the market.
Written after the close on ·
Earnings report
Next report: November 10. On its last 15 report days Embla Medical usually moved about 3.4%. On a normal day it moves 0.6%.
October 20, 2026: −5.27%July 21, 2026: +3.42%April 28, 2026: −3.44%February 3, 2026: +0.32%
Why today
15,968 news analyzed todayEmbla Medical fell, moving in line with the market.
Over the last five trading days it rose clearly, more than the market.
The move was an ordinary size for the stock, and trading volume was well above normal.
No company news explains the last session's move.
Earlier this week the company reported share buybacks, and its next earnings report is due on 10 November 2026.
Today's move of −0.53% was 0.9 times a normal day's 0.6%. OMX Copenhagen 25 moved −0.64% on the same day.
Embla Medical −0.53%OMX Copenhagen 25 −0.64%In step with the market
What analysts expect, and how often they have been right
Analysts’ estimates for Embla Medical.
Embla Medical earned more than expected in 4 out of 8 reports.
Not in the chart because no estimate and result are available: 1 of the 9 reports in this period, the latest on April 28, 2026.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 5 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 27.95 DKK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expected$
Next reported quarter: expected earnings per share of 0.44 DKK (November 10). For the current fiscal year, expected earnings per share changed from 1.53 DKK three months ago to 1.54 DKK now. 2026 estimate: 1.54 DKK. 2027 estimate: 1.74 DKK.
What the key figures say about Embla Medical
The figures connect what Embla Medical earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: $0.10–$0.20. Peers: Vitrolife -36.60 SEK, Nolato 2.50 SEK, Elekta -0.95 SEK.
What the company sold during the year.
2022–2025: $719M–$929M. Peers: Vitrolife 3.4 bn SEK, Nolato 9.6 bn SEK, Elekta 16.6 bn SEK. 2026 estimate: $1.0B ($1.0B–$1.0B). 2027 estimate: $1.1B ($1.1B–$1.1B).
The percentage of revenue left after the costs of running the business.
2022–2025: 9.3%–13.4%. Peers: Vitrolife −137.9%, Nolato 10.0%, Elekta 1.7%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 6.7%–9.4%. Peers: Vitrolife −46.3%, Nolato 11.8%, Elekta −4.3%.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 0.00 DKK–0.15 DKK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 0.0%–0.0%. Peers: Vitrolife 0.9%, Nolato 3.3%, Elekta 4.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 2.33–3.46. Peers: Vitrolife 0.85, Nolato 1.22, Elekta 2.45.
More key figures
Cash left after investments, divided by the number of shares.
2022–2025: $0.08–$0.23. Peers: Vitrolife 4.99 SEK, Nolato 4.28 SEK, Elekta 4.04 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 48.0%–51.5%.
What to watch next, and why
The earnings report shows how Embla Medical's revenue and profit have changed.
- Earnings report
The earnings report shows how Embla Medical's revenue and profit have changed.
Add to calendar
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Embla Medical usually moved about 3.4%. On a normal day it moves 0.6%.
−5.27% Why? +3.42% −3.44% +0.32%
10,000 DKK in Embla Medical bought on November 7, 2016 is worth 11,600 DKK today, with dividends reinvested.
The same amount in OMX Copenhagen with dividends would have become 25,700 DKK.
What would 10,000 DKK in Embla Medical be worth today? →
What would 10,000 DKK in Embla Medical be worth today?
11,600 DKK
with dividends reinvested, bought on November 7, 2016. The same amount in OMX Copenhagen with dividends would have become 25,700 DKK.
The five biggest days of the journey
· −11.3% · the whole market rose 0.4% the same day
· +10.7% · the whole market rose 1.3% the same day
· −10.0% · the whole market fell 8.0% the same day
· −9.4% · the whole market fell 1.5% the same day
· −8.7% · the whole market fell 1.0% the same day
Earlier days
+3.52% market +1.75% Embla Medical rose clearly over the week, more than the wider Copenhagen market, which also rose clearly. Read →
Embla Medical rose clearly over the week, more than the wider Copenhagen market, which also rose clearly.
A share buyback program, under which the company buys back its own shares to shrink its share capital, was active during the week and likely supported demand.
Its latest session saw a slight fall, moving in line with the market.
Trading volume was well above its usual level that day.
+3.12% market −0.23% Embla Medical rose very sharply without company news. Read →
Embla Medical rose very sharply without company news.
Over the same session, OMX Copenhagen 25 fell slightly, so the stock moved against the market.
Over the last five trading days, Embla Medical rose sharply while the market rose clearly, so it outpaced the index.
Trading volume was about 15 times a normal session, which suggests heavy buying interest.
+1.11% market +1.82% Embla Medical rose clearly. Read →
Embla Medical rose clearly.
No company news from that session explains the move.
Over the last five trading days the stock was roughly unchanged while OMX Copenhagen 25 rose sharply.
Earlier news includes a share buyback announcement, which is a company buying back its own shares to shrink its capital.
Next, the company reports earnings on Tuesday 2 February 2027.
−1.64% market +0.22% Embla Medical fell sharply, moving against the market. Read →
Embla Medical fell sharply, moving against the market.
Over the same day OMX Copenhagen 25, the main Danish index, rose slightly.
No company news from the last session explains the drop.
Over the last five trading days the shares rose slightly, moving less than the market, which rose sharply.
The buyback, where the company repurchases its own shares to return capital, was announced the day before, but its size is small.
+1.48% market +0.59% Embla Medical rose, and a share buyback announcement is the reason. Read →
Embla Medical rose, and a share buyback announcement is the reason.
The company announced that day that it bought back shares in late October at an average price in the high twenties.
The buyback runs until the end of the year.
Over the last five trading days the stock rose slightly while OMX Copenhagen 25 rose sharply, so it lagged the market.
Healthcare peers on Nasdaq Copenhagen moved up over the same days.
+1.69% market +4.94% Embla Medical rose slightly over the week, moving less than the market, which rose very sharply. Read →
Embla Medical rose slightly over the week, moving less than the market, which rose very sharply.
The company cut its full-year growth outlook on 20 October, before this week, and its quarterly earnings missed expectations, which kept sentiment weak.
A share buyback program, where the company buys back its own shares to reduce capital, was running through the week and gave modest support.
The next earnings report is due on 2 February 2027.
+1.68% market +2.80% Embla Medical rose sharply, without company news. Read →
Embla Medical rose sharply, without company news.
No company news from that session explains the move.
Over the last five trading days it rose sharply, in line with OMX Copenhagen 25.
The Q3 2026 results, which missed expectations and narrowed full-year guidance, came out before that session and weigh on sentiment.
Next earnings report: Tuesday 2 February 2027.
−1.47% market +0.57% Embla Medical fell, moving against a rising market. Read →
Embla Medical fell, moving against a rising market.
The shares had risen clearly over the last five trading days, moving in line with the OMX Copenhagen 25.
Earlier, Embla Medical cut its 2026 growth outlook when it reported Q3 results, saying patient care sales were below expectations.
Investors often react sharply to such guidance cuts, and the shares were already pressured after that report.
+2.26% market +1.34% Embla Medical rises sharply on share buyback news. Read →
Embla Medical rises sharply on share buyback news.
Embla Medical rose sharply in the last session, moving more than the market, which also rose sharply.
The most likely driver is the company's share buyback announcement of 26 October, which showed it bought back 51,000 shares at an average of DKK 26.55.
Over the last five trading days, Embla Medical fell slightly while OMX Copenhagen 25 rose sharply, so it moved against the market.
Trading was heavy, about twice a normal session, and the shares remain well below their highest close of the past year.
+1.34% market −0.63% Embla Medical rose clearly, while the market fell clearly. Read →
Embla Medical rose clearly, while the market fell clearly.
Embla Medical moved against OMX Copenhagen 25, which fell clearly that session.
No company news from the last session explains the rise.
Over the last five trading days the stock fell sharply, while the market rose slightly.
Earlier this week the company reported Q3 results that missed expectations and narrowed its full-year growth outlook.
−3.98% market +0.86% Embla Medical fell sharply over the last five trading days, moving against a slightly rising Copenhagen market. Read →
Embla Medical fell sharply over the last five trading days, moving against a slightly rising Copenhagen market.
The drop followed its Q3 2026 report earlier this week, which missed expectations.
Sales growth was modest and Patient Care, a clinic-based segment, was flat, so the company cut its full-year organic sales growth outlook to about 5%.
Trading was heavy, about twice a normal session, and the share price now sits near its lowest close of the past year.
+0.58% market +0.06% Embla Medical rose slightly last session, against a flat market. Read →
Embla Medical rose slightly last session, against a flat market.
In the last session it rose slightly while the market was roughly flat, so the move was ordinary.
Over the last five trading days the stock fell sharply, while the market rose clearly.
The fall followed earnings that missed expectations and a cut to the full-year growth outlook, announced earlier this week.
The company's Patient Care unit did not grow, as integration work in clinics has slowed volume growth.
−5.27% market +0.44% Embla Medical fell sharply that day after cutting its 2026 growth outlook. Read →
Embla Medical fell sharply that day after cutting its 2026 growth outlook.
Against the market, OMX Copenhagen 25 rose slightly over the same days, so the stock moved clearly apart from it.
That day's fall came on the Q3 2026 report, which is the company's quarterly results release, published during the session; the report was a substantial miss on expectations, with the fall in the shares very sharp.
Management narrowed full-year organic sales growth, meaning growth excluding acquisitions and currency effects, to about 5% from 5-7%, mainly because the Patient Care clinic business stayed flat as integration work slowed patient volume growth.
Over the last five trading days the stock fell sharply, a big move for it, roughly twice a normal five-day stretch and one seen about 12 times in the past year.
Learn more · Why do stocks move on earnings day? · Why do stocks go up and down?